Endocrine Pharmacology: Advances in the Pharmacotherapy of Metabolic and Hormonal Disorders

This chapter reviews the pharmacological management of endocrine and metabolic conditions including diabetes mellitus, thyroid disorders, adrenal dysfunction, and reproductive endocrinopathies, with emphasis on novel drug mechanisms and pipeline agents. It evaluates incretin-based therapies, dual and triple receptor agonists, and gene-silencing approaches, situating these advances within the broader context of metabolic disease pharmacology.